1. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma
   Chang Liu et al, 2019, Experimental Cell Research CrossRef
2. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters
   Mariela Montaño-Samaniego et al, 2020, Frontiers in Oncology CrossRef
3. Gene-Directed Enzyme Prodrug Therapy by Dendrimer-Like Mesoporous Silica Nanoparticles against Tumor Cells
   Vicente Candela-Noguera et al, 2021, Nanomaterials CrossRef
4. ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma
   Xiuli Mu et al, 2020, Cancer Gene Therapy CrossRef
5. Neural differentiation of glioblastoma cell lines via a herpes simplex virus thymidine kinase/ganciclovir system driven by a glial fibrillary acidic protein promoter
   Elizabeth Wei-Chia Luo et al, 2021, PLOS ONE CrossRef
6. β2-Adrenergic receptor agonist enhances the bystander effect of HSV-TK/GCV gene therapy in glioblastoma multiforme via upregulation of connexin 43 expression
   Saereh Hosseindoost et al, 2022, Molecular Therapy - Oncolytics CrossRef
7. Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer
   Ana Rosa Rama Ballesteros et al, 2020, Cancer Gene Therapy CrossRef
8. Inorganic Nanomaterial‐Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities
   Guanyou Lin et al, 2021, Advanced Functional Materials CrossRef